Cranberry vs D-Mannose for UTI Prevention: What the Trials Show

Cranberry and D-mannose are the two best-known supplements for preventing urinary tract infections. One has a large body of trials with a modest benefit; the other was tested in a big, placebo-controlled trial and did not work. This page is unpaid, lists no prices and recommends no brand.

Quick Answer: Cranberry has the better evidence. A 2023 Cochrane review of 50 trials (8,857 people) found cranberry products cut symptomatic, culture-verified UTIs by about 30% overall (risk ratio 0.70) and by about 26% in women with recurrent UTIs (RR 0.74), with the biggest effects in children and after bladder procedures. D-mannose failed its best test: in a 2024 placebo-controlled trial of 598 women with recurrent UTI, 51.0% taking 2 g daily and 55.7% taking placebo still had a medically attended UTI within 6 months, a difference that was not statistically significant. Neither treats an infection that has already started. If you have symptoms, see a clinician.

Cranberry vs D-Mannose at a Glance

FeatureCranberryD-mannose
What it isFruit extract, juice or capsules containing proanthocyanidins (PACs)A simple sugar sold as a powder or capsules
Proposed mechanismPACs may stop E. coli sticking to the bladder wall (Cochrane)Proposed to bind bacteria so they are flushed out in urine
Best evidenceCochrane 2023: 50 RCTs, 8,857 participantsJAMA Intern Med 2024: one RCT, 598 women, 99 UK primary care centres
Result for preventionOverall RR 0.70 (95% CI 0.58–0.84); women with recurrent UTI RR 0.74 (0.55–0.99)51.0% vs 55.7% with a UTI on placebo; risk difference −5% (95% CI −13% to 3%), P = .26
Who may benefitWomen with recurrent UTIs, children, people with UTI risk after a bladder procedureNo group shown to benefit in the primary-care trial
Little or no benefitInstitutionalised older adults, pregnant women, incomplete bladder emptyingNot applicable (no overall effect)
Treats an existing UTI?No (NCCIH)No trial evidence
Side effectsGenerally safe; large amounts can cause stomach upset and diarrhea; warfarin evidence conflictingNot described as a main finding in the trial abstract; check with your clinician

Cross-trial note: these are different study designs in different populations, so the numbers are not a head-to-head comparison. No trial reviewed here compared the two supplements directly.

What the Evidence Shows for Cranberry

The Cochrane Collaboration has updated its cranberry review five times since 1998. The November 2023 update (Williams et al.) added 26 new studies for a total of 50 randomised trials with 8,857 participants. Forty-five compared cranberry with placebo, water or no specific treatment, and 26 of those could be pooled for the main outcome, symptomatic and culture-verified UTI.

Pooled, cranberry products reduced UTI risk with moderate-certainty evidence (RR 0.70, 95% CI 0.58 to 0.84). The review split the results by who was studied:

GroupStudies / participantsRisk ratio (95% CI)Interpretation
Women with recurrent UTIs8 / 1,5550.74 (0.55–0.99)Probably reduces risk
Children5 / 5040.46 (0.32–0.68)Probably reduces risk
UTI risk after an intervention (e.g. bladder procedure)6 / 1,4340.47 (0.37–0.61)Probably reduces risk
Institutionalised older adults3 / 1,4890.93 (0.67–1.30)Little or no benefit
Pregnant women3 / 7651.06 (0.75–1.50)Little or no benefit
Neuromuscular bladder dysfunction, incomplete emptying3 / 4640.97 (0.78–1.19)Little or no benefit (low certainty)

Other findings from the review:

  • Versus antibiotics: cranberry may make little or no difference to symptomatic, culture-verified UTI (2 studies, 385 participants, RR 1.03, 95% CI 0.80–1.33). That is a small evidence base, not proof the two are equivalent.
  • Versus probiotics: cranberry may reduce UTIs more (3 studies, 215 participants, RR 0.39).
  • Juice vs tablets, and dose: it is unclear whether juice and tablets differ, and the review found no difference between low, moderate and high PAC doses; certainty was very low.
  • Side effects: gastrointestinal side effects probably do not differ much from placebo (RR 1.33, 95% CI 1.00–1.77).

The National Center for Complementary and Integrative Health (NCCIH) gives a more cautious summary: cranberry products may lower the overall risk of symptomatic recurrent UTIs in women by about 25 percent, but “the effectiveness of cranberry is still in question because of inconsistent findings.” It notes that studies in women undergoing gynecological surgery and in people with multiple sclerosis did not find a benefit. Since 2020 the FDA has allowed a qualified label claim that there is “limited” evidence that daily cranberry supplements may reduce the risk of recurrent UTI in healthy women.

What the Evidence Shows for D-Mannose

D-mannose is popular, but its best test was negative. The 2024 trial by Hayward and colleagues in JAMA Internal Medicine was a double-blind, placebo-controlled trial across 99 primary care centres in the UK. It enrolled women 18 or older with at least 2 UTIs in the previous 6 months or 3 in 12 months. Of the 598 women randomised (mean age 58), 303 received 2 g of D-mannose powder daily and 295 received matched placebo for 6 months.

  • Primary outcome (a further clinically suspected UTI for which the woman contacted ambulatory care within 6 months): 150 of 294 (51.0%) on D-mannose vs 161 of 289 (55.7%) on placebo.
  • Difference: −5% (95% CI −13% to 3%; P = .26), not statistically significant. Per-protocol, imputation and preplanned subgroup analyses gave similar results.
  • Secondary outcomes (symptom duration, antibiotic use, time to next UTI, number of suspected UTIs, hospital admissions) did not differ significantly.
  • Authors’ conclusion: D-mannose should not be recommended for prophylaxis in this patient group.

Earlier promising D-mannose studies were based in secondary care, as the trial authors note; this one tested community primary care. Its limits: it measured clinically suspected UTIs (those for which women sought care) rather than only culture-confirmed ones, and it tested a single dose (2 g daily) taken as prevention, not at symptom onset. Within those limits, a daily 2 g dose did not prevent medically attended UTIs in women with recurrent infections.

Who Should Choose What

  • Women with recurrent UTIs who want a non-antibiotic option: cranberry is the one with supportive trial evidence, though the effect is modest and findings are inconsistent. Treat it as an add-on to, not a replacement for, advice from your clinician.
  • Parents of children with frequent UTIs: the Cochrane analysis in children showed the largest relative effect, but it was 5 studies and 504 children. Ask your child’s pediatrician before giving any supplement.
  • After a bladder procedure: cranberry probably lowered UTI risk in this group; discuss it with the surgical or urology team.
  • Pregnancy, older adults in care homes, or incomplete bladder emptying: the Cochrane review found little or no benefit from cranberry. Talk to your clinician about other prevention.
  • D-mannose: based on the largest placebo-controlled trial, it is hard to recommend for prevention. If you already use it and feel it helps, the trial does not rule out individual response, but it does not support the claim.
  • If you have frequent UTIs at all: see a clinician. Recurrent infections deserve evaluation and, where appropriate, prescribed prevention. See also our vaginal probiotics guide and probiotic strains comparison for how probiotics fit in.

How to Read a Cranberry Label

  • PAC content: the active compounds are PACs. NCCIH notes that processing cranberries into tablets or capsules can reduce PAC concentration, and Cochrane says the suggested dose may not be on the package. Look for a stated PAC amount rather than only “cranberry extract.”
  • Juice cocktails: the FDA label claim for cranberry juice beverages is weaker (“limited and inconsistent” evidence), per NCCIH.
  • Third-party testing: FDA does not approve dietary supplements before they are sold, so an independent testing seal can help confirm what is in the bottle.
  • Interactions: if you take warfarin or other medicines, talk to your clinician first; evidence on a warfarin interaction is conflicting.

When to See a Doctor

Neither supplement is a treatment. NIDDK advises contacting a health care professional if you have symptoms of a bladder infection:

  • A burning feeling when you urinate
  • Frequent or intense urges to urinate, even with little urine to pass
  • Pain or discomfort in the lower abdomen
  • Cloudy, bloody or strong-smelling urine

Bladder infections can spread to the kidneys. Get quick treatment if you also have fever and chills, nausea or vomiting, or pain in your back, side or groin.

Frequently Asked Questions

Which is better for preventing UTIs, cranberry or D-mannose?

Cranberry has the stronger evidence. A 2023 Cochrane review of 50 trials found it reduced symptomatic, culture-verified UTIs (RR 0.70), including in women with recurrent UTIs (RR 0.74). A 2024 trial of 598 women found 2 g of D-mannose daily did not reduce UTIs.

Does D-mannose work for UTIs?

The best placebo-controlled trial says no for prevention. In 598 UK women with recurrent UTI, 51.0% taking D-mannose and 55.7% taking placebo had a medically attended suspected UTI within 6 months (risk difference -5%, 95% CI -13% to 3%, P = .26). It was not tested as a treatment for an active infection in that trial.

Can cranberry or D-mannose treat a UTI that has already started?

No. NCCIH says cranberry is not recommended as a treatment for an existing UTI in any population, and people who think they have a UTI should see a health care provider. The same applies to D-mannose, which has no trial evidence as a treatment.

Who gets the most benefit from cranberry?

The Cochrane review found a likely benefit in women with recurrent UTIs, children, and people prone to UTIs after a bladder procedure. It found little or no benefit in institutionalised older adults, pregnant women, or adults with incomplete bladder emptying.

Is cranberry juice or a cranberry pill better?

The Cochrane review could not say; certainty was very low. NCCIH notes that turning cranberries into tablets or capsules can lower the concentration of proanthocyanidins (PACs), the compounds thought to work, and that products rarely state the PAC dose.

Is cranberry safe?

Taken by mouth it is generally thought to be safe. Very large amounts can cause stomach upset and diarrhea, especially in young children. Evidence on an interaction with warfarin is conflicting, so ask your clinician if you take it.

When should I see a doctor for a UTI?

Contact a health care professional for any symptoms of a bladder infection, such as burning with urination, frequent urges, lower belly pain or cloudy, bloody or strong-smelling urine. Seek quick care for fever and chills, nausea or vomiting, or back, side or groin pain, which can signal a kidney infection.

Sources

Medical disclaimer: This article is for educational purposes and does not replace medical advice. Consult a licensed healthcare provider before starting any supplement, medication, or treatment — particularly if you are pregnant, breastfeeding, taking other medications, or have a diagnosed medical condition.